Ablynx and Merck Serono Form Third Nanobody® Collaboration
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 11 (Table of Contents)
Published: 28 Nov-2011
DOI: 10.3833/pdr.v2011.i11.1618 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Belgium’s Ablynx has formed its third collaboration with Merck Serono to co-discover and co-develop Nanobody® therapies, this time against two osteoarthritis targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS